Yes. I am not sure why they just didn’t show all months and then use a trend line. Someone quickly glancing might not notice the uneven data interval distribution along the X axis. I want to take a position in PNV, but, as mentioned by others the reporting quirks by management means it remains on the watchlist for the time being.

Agree with @mikebrisy, @Rick and @NewbieHKon this obvious (why do it??) manipulation of data.

Such a missed opportunity to be transparent when telling a really good story.

As mentioned here before I am out of PNV as I don't trust the board / management.

That's not to say he can't be trusted, it just that for me trust needs to be earned over time, not assumed and then chipped away over time.

I hope PNV does well but I also hope their overly promotional Chair moves on like he has at other promising toys he has discarded when he loses interest.

Great Aussie story and genuinely life-changing tech for patients, but for me that's just interesting, and missing too many other ingredients to be a potentially rewarding investment.

We all have our own strategy which is as much about what you won't do.

For the backstory on chair's involvement in this business have a look at this 2020 IV on how he made money floating the company and ended up becoming one of it's largest shareholders for free ...

https://www.youtube.com/watch?v=w1MiHWqJqCQ&feature=youtu.be

Nice work if you can get it